Watchlist Price Alert

Corcept Therapeutics (CORT)

NASDAQ: CORT · Real-Time Price · USD

70.84

0.78 (1.11%)

At close: Jun 16, 2025, 3:59 PM

70.40

-0.62%

Pre-market: Jun 17, 2025, 07:34 AM EDT

Corcept Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	675.04M	482.38M	401.86M	365.98M	353.87M	306.49M	251.25M	159.2M	81.32M
Cost of Revenue	10.88M	6.48M	5.38M	5.28M	5.58M	5.5M	5.21M	3.55M	2.06M
Gross Profit	664.16M	475.89M	396.47M	360.7M	348.29M	300.98M	246.03M	155.65M	79.26M
Operating Income	136.95M	107.28M	112.63M	124.48M	128.2M	111.61M	89.5M	52.85M	10.18M
Interest Income	24.54M	17.27M	3.56M	529K	3.4M	5.07M	2.66M	n/a	n/a
Pretax Income	161.49M	124.56M	116.19M	125.01M	131.6M	116.68M	92.15M	52.81M	8.14M
Net Income	139.73M	106.14M	101.42M	112.51M	106.01M	94.18M	75.41M	129.12M	8.14M
Selling & General & Admin	280.32M	184.26M	152.85M	122.36M	105.33M	100.36M	81.29M	62.42M	45.24M
Research & Development	246.89M	184.35M	130.99M	113.86M	114.76M	89.02M	75.25M	40.38M	23.84M
Other Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	527.21M	368.61M	283.84M	236.22M	220.09M	189.38M	156.54M	102.79M	69.08M
Interest Expense	n/a	n/a	3.56M	n/a	n/a	5.07M	2.66M	49K	2.04M
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	538.09M	375.09M	289.22M	241.5M	225.67M	194.88M	161.75M	106.35M	71.14M
Income Tax Expense	20.28M	18.42M	14.77M	12.49M	25.59M	22.5M	16.74M	-76.32M	n/a
Shares Outstanding (Basic)	103.23M	103.56M	106.79M	115.65M	115.41M	114.35M	125.68M	113.53M	110.57M
Shares Outstanding (Diluted)	113.48M	111.74M	115.97M	125.96M	124.19M	122.57M	126.69M	124.52M	116.14M
EPS (Basic)	1.35	1.02	0.95	0.97	0.92	0.82	0.60	1.14	0.07
EPS (Diluted)	1.23	0.94	0.87	0.89	0.85	0.77	0.60	1.04	0.07
EBITDA	136.95M	108.32M	112.63M	124.48M	130.44M	113.78M	89.73M	52.96M	10.27M
EBIT	136.95M	107.28M	116.19M	125.01M	128.2M	111.61M	89.5M	52.85M	10.07M
Depreciation & Amortization	n/a	1.04M	2.97M	3.07M	2.24M	2.17M	236K	106K	87K